169758-66-1Relevant articles and documents
Process for the manufacture of 3-N-N-dicyclobutylamino-8-fluoro-3, 4-dihydro-2H-1-benzopyran-5-carboxamide
-
, (2008/06/13)
A process for the manufacture of the racemic compound of the formula (I), its R-enantiomer (formula R-(I)) and its S-enantiomer (formula S-(I)), and pharmaceutically acceptable salts and/or solvates thereof, as well as new intermediates obtained and used in the process.
Combination of 5-HT uptake inhibitor with a selective 5-HT1A antagonist
-
, (2008/06/13)
The invention relates to a combination of a first component (a) which is a 5-HT reuptake inhibitor and a second component (b) which is selective 5-HT 1A antagonist of the general formula wherein R 1 is n-propyl or cyclobutyl; R 2 is isopropyl, tertiary bu
USE OF 5-HT1A RECEPTOR ANTAGONISTS FOR THE TREATMENT OF URINARY INCONTINENCE
-
, (2008/06/13)
The present invention discloses compositions and methods for treating neuromuscular dysfunction of the lower urinary tract in mammals, including humans, using serotonin 5-HT 1A receptor antagonist compounds that exert their inhibitory effects via pre-syna
(R)-5-CARBAMOYL-8-FLUORO-3-N,N-DISUBSTITUTED-AMINO-3,4-DIHYDRO-2H-1-BENZOPYRANS
-
, (2008/06/13)
Compounds of the general formula STR1 wherein R 1 is n-propyl or cyclobutyl;R 2 is isopropyl, tertiary butyl, cyclobutyl, cyclopentyl or cyclohexyl;R 3 is hydrogen;R 4 is hydrogen or methyl;as (R)-enantiomer in the form of free ba